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A B ST R AC T  
 
Spindle cell rhabdomyosarcoma (RMS) is a rare variant of embryonal rhabdomyosarcoma. This 
tumor commonly involves paratesticular region of young males. Herein we report a case report of 
right paratesticular spindle cell rhabdomyosarcoma in a 16-year-old boy, who was referred to us for 
painless right scrotal mass. Staging computerized tomography (CT) showed no nodal or distant 
metastasis. The right radical inguinal orchidectomy was performed. Diagnosis of paratesticular 
spindle cell rhabdomyosarcoma was confirmed by histopathological and immunohistochemical 
examination. Paratesticular spindle cell RMS is a rare tumor and morphologically it may mimic other 
spindle cell neoplasms. Immunohistochemistry plays a pivotal role in its diagnosis. Making a correct 
diagnosis is crucial owing to the different treatment modalities available for this tumor          
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Introduction 
Being a highly malignant soft-tissue sarcoma, 
rhabdomyosarcoma (RMS) has an incidence of 
approximately 4.5 cases per 1 million children 
and young adults. Paratesticular RMS among 
children and young adults are relatively rare, 
accounting 7% of all RMS. Spindle cell RMS 
are rare variant of embryonal RMS; only 3% of 
all RMS cases reported in Intergroup 
Rhabdomyosarcoma Study Group (IRSG) [1-
5]. Treatment modality consists of surgical 
resection of tumor, radiotherapy, and/or 
adjuvant chemotherapy. Prognosis of spindle 
cell RMS is relatively poor [5]. Herein, we 
report a case report of right paratesticular 
spindle cell rhabdomyosarcoma in a 16-year-
old boy, who was referred to us for painless 
right scrotal mass, due to its rarity and features 
in its diagnosis. 
 
Case report 
A 16 years old Chinese Malaysian boy was 
referred from district hospital for one-month 
history of painless right scrotal swelling. He 
had no tuberculosis contact before. He is a 
Form 5 student with uneventful perinatal 
period. He was adhered to standard 
immunization schedule set by Ministry of 
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Health Malaysia. Other than well-controlled 
childhood bronchial asthma, he has no other 
co-morbid, past surgical history or family 
history of cancer. 
On clinical examination, there was a right 
scrotal mass measuring about 8x6cm. It was 
hard in consistency, has a regular surface and 
well-defined margin, but it was not tethered to 
the scrotal skin. The left hemiscrotum was 
normal. Abdomen was unremarkable, and no 
inguinal lymphadenopathy was noted. There 
was no syndromic facies or obvious 
musculoskeletal deformities as well. Clinical 
diagnosis of primary right testicular tumor was 
made. Laboratory investigations revealed 
normal range of serum -fetoprotein (AFP), 
lactate dehydrogenase (LDH) and -human 
chorionic gonadotropin (bhCG). Ultrasound 
examination of scrotum and testes revealed a 
well-defined homogenous hypoechoic right 
scrotal mass measuring 3.9x3.7x4.5cm with 
positive color Doppler signal which suggestive 
of right testicular tumor. The thoraco-
abdominopelvic computerized 
tomography scan did not reveal any nodal or 
distant metastases. Right radical orchidectomy 
was performed via inguinal approach.  
On gross examination, the tumor was globular 
and well-encapsulated measuring 
7.9x6.2x5cm. On cut section, it has 
homogenous tan brownish surface with 
minimal area of hemorrhage. The tumor was 
found adhering to the right testis which is 
unremarkable on cut section. Microscopic 
examination demonstrated a tumor composed 
of spindle, neoplastic cells with ovoid to 
elongated nuclei and pale, eosinophilic 
cytoplasm (Fig. 1a). Scattered 
rhabdomyoblasts are also seen. In some areas, 
neoplastic cells were arranged in microalveolar 
pattern with dense stromal sclerosis, imparting 
a pseudovascular appearance (Fig. 1b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Light microscopy shows (a) spindle 
cells in fascicles with occasional 
rhabdomyoblasts seen (H&E, 100x) and (b) 
sclerosing area of tumors imparting a 
pseudovascular appearance (H&E, 400x). 
 
Mitoses were 10/10 hpf. The adjacent 
testicular parenchyma, rete testis and 
spermatic cord are unremarkable. On 
immunohistochemistry, the tumor cells are 
positive for Myogenin (Fig. 2a), Actin (Fig. 
2b) and Desmin (Fig. 2c) and negative for 
Pancytokeratin, CD117, PLAP, SALL4, LCA 
and CD 20. Based on the fore mentioned 
histopathological features, diagnosis of right 
paratesticular RMS with spindle cell variant 
was made. The tumor was staged as stage 1 (T2 
N0 M0) according to TNM staging system for 
RMS. His parents refused to subject him for 
adjuvant chemotherapy and he is still alive 6 
months post-operatively. 
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Discussion 
Being a highly malignant soft-tissue sarcoma, 
rhabdomyosarcoma (RMS) has an incidence of 
approximately 4.5 cases per 1 million children 
and young adults. Paratesticular RMS among 
children and young adults are relatively rare, 
accounting 7% of all RMS. Spindle cell RMS 
are rare variant of embryonal RMS; only 3% of 
all RMS cases reported in Intergroup 
Rhabdomyosarcoma Study Group (IRSG) [1]. 
Paratesticular spindle cell RMS has male 
preponderance [2,3] and is more common in 
children and adolescents with mean age of 7 
years [4]. It is a rapid growing tumor but 
usually spares the scrotal skin [5]. Most cases 
of RMS are sporadic, nevertheless, there is 
approximately 7 to 8 percent of them may be 
associated with inherited syndrome such as 
neurofibromatosis, Li-Fraumeni syndrome, 
Beckwith-Wiedemann syndrome, and Costello 
syndrome [6-9]. 
On gross examination, it often displayed a 
white or tan whorled appearance occasionally 
accompanied by necrosis or cystic 
degeneration. On microscopic examination 
spindle cell RMS often shown fascicular 
elongated cells with central nuclei and 
eosinophilic fibrillary cytoplasm with a small 
proportion of rhabdomyoblasts [10]. 
Differential diagnoses of spindle cell RMS are 
leiomyosarcoma,     myofibroblastic    sarcoma,  
 
 
 
 
 
 
 
 
 
 
 
 
fibrosarcoma, malignant peripheral nerve 
sheath tumor with rhabdomyoblastic 
differentiation and desmoplastic melanoma; 
owing to morphological similarities between 
these neoplasms. Of them, leiomyosarcoma is 
top in the list. Therefore, 
immunohistochemistry plays an important in 
making the accurate diagnosis and thence 
correct treatment. Spindle cell RMS 
consistently reacts with myogenic markers 
such as Desmin, Titin, Troponin D, 
Myoglobin, MyoD1, Myogenin and Actin 
[11]. Generally, RMS is staged by using 
Tumor, Node, and Metastasis (TNM) system. 
This system assigns one of four disease stages 
(from 1 through 4) based upon the site and size 
of the primary lesion, regional nodal 
involvement, and presence or absence of 
metastatic disease (Table 1). Favorable disease 
sites include the orbit and eyelid, other non-
parameningeal head and neck locations, and 
non-bladder/prostate genitourinary tumors 
(e.g. paratesticular tumors). Extremities, 
bladder and prostate, cranial parameningeal 
sites, trunk and peritoneum, on the other hand, 
suggest unfavorable disease. In our case, it was 
staged as Stage 1 which points toward 
favorable disease.  
Paratesticular RMS is currently being treated 
with protocols    similar to other RMS because  
Fig. 2. On histochemistry, the tumour cells are positive for (a) Myogenin, (b) Actin and (c) Desmin. 
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they are rare and limited research has been 
done. Radical orchidectomy by the inguinal 
approach with spermatic cord ligation remains 
the vital act for histological diagnosis and 
constitutes the first step of treatment regardless 
of the stage of the disease [12]. Adjuvant 
chemotherapy should be administered since 
the tumor is chemosensitive. This therapeutic 
approach consists of giving actinomycin D, 
vincristine, and cyclophosphamide (IRS-IV 
protocol). 
 
Conclusion 
Paratesticular spindle cell RMS is a rare 
tumour occurring in children and adolescents. 
Morphologically it may mimic other spindle 
cell neoplasms. Thus immunohistochemistry 
plays a pivotal role in its diagnosis. Making a 
correct diagnosis is crucial owing to the 
different treatment modalities available for this 
tumour.  
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